TREATMENT PATTERNS AND OUTCOMES IN THE FRENCH COHORT OF PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA (MELODY STUDY): A RETROSPECTIVE LONGITUDINAL SURVEY

被引：0
|
作者：
Bedane, C. [1 ]
Leccia, M. T. [2 ]
Sassolas, B. [3 ]
Mansard, S. [4 ]
Guillot, B. [5 ]
Mortier, L. [6 ]
Robert, C. [7 ]
Saiag, P. [8 ]
Truchetet, F. [9 ]
Oukessou, A. [10 ]
Bregman, B. [10 ]
Lebbe, C. [11 ]
机构：
[1] Hop Dupuytren, Limoges, France
[2] Hop Michallon, La Tronche, France
[3] Hop Morvan, Brest, France
[4] Hop Hotel Dieu, Clermont Ferrand, France
[5] Hop St Eloi, Montpellier, France
[6] Hop Claude Huriez, Lille, France
[7] Inst Gustave Roussy, Villejuif, France
[8] Hop Ambroise Pare, Boulogne, France
[9] Hop Beauregard, Thionville, France
[10] Bristol Myers Squibb Co, Rueil Malmaison, France
[11] Hop St Louis, Paris, France
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)72007-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A273 / A273
页数：1
相关论文
共 50 条
  • [41] A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma
    Kudchadkar, Ragini
    Ernst, Scott
    Chmielowski, Bartosz
    Redman, Bruce G.
    Steinberg, Joyce
    Keating, Anne
    Jie, Fei
    Chen, Caroline
    Gonzalez, Rene
    Weber, Jeffrey
    CANCER MEDICINE, 2015, 4 (05): : 643 - 650
  • [42] A phase II study of YM155, a novel survivin suppressant, administered by 168 hour continuous infusion in patients with unresectable stage III or stage IV melanoma
    Gonzalez, R.
    Lewis, K.
    Samlowski, W.
    Cranmer, L.
    Catlett, J.
    Kirkwood, J.
    Whitman, E.
    Lawson, D.
    Bartels, P.
    Drake, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Phase III randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) versus DTIC alone as first-line treatment in patients with unresectable stage III or IV melanoma
    Wolchok, J. D.
    Thomas, L.
    Bondarenko, I. N.
    O'Day, S.
    Weber, J. S.
    Garbe, C.
    Francis, S.
    Ibrahim, R. A.
    Hoos, A.
    Robert, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
  • [44] A phase I study of intratumoral injection of ipilimumab and interleukin-2 in patients with unresectable stage III-IV melanoma.
    Bowen, Randy Christopher
    Meek, Stephanie
    Williams, Matthew
    Grossmann, Kenneth F.
    Andtbacka, Robert Hans Ingemar
    Bowles, Tawnya Lynn
    Hyngstrom, John Robert
    Leachman, Sancy Ann
    Grossman, Douglas
    Holmen, Sheri L.
    VanBrocklin, Matthew W.
    Khong, Hung T.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Phase II Study of Nab-Paclitaxel and Bevacizumab as First-line Therapy for Patients with Unresectable Stage III and IV Melanoma
    Spitler, Lynn E.
    Boasberg, Peter
    O' Day, Steven
    Hamid, Omid
    Cruickshank, Scott
    Mesko, Shane
    Weber, Robert W.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (01): : 61 - 67
  • [46] A randomized phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM).
    Jamal, Rahima
    Belanger, Karl
    Friedmann, Jennifer Elisabeth
    Ayoub, Jean-Pierre M.
    Cocolakis, Eftihia
    Kazemi, Shirin
    Dionne, Jeanne
    Lambert, Caroline
    Le, H. B.
    Van Kempen, Leon
    Spatz, Alan
    Lapointe, Rejean
    Miller, Wilson H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] Survival and Prognosis Analysis of Unresectable Masaoka-Koga Stage III-IV Thymoma: A Retrospective Study
    Wang, X.
    Feng, Q.
    Zhai, Y. R.
    Bi, N.
    Liang, J.
    Zhou, Z.
    Xiao, Z.
    Chen, D.
    Lv, J.
    Hui, Z.
    Wang, L.
    Li, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E666 - E667
  • [48] Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
    Cybulska-Stopa, Bozena
    Skoczek, Marta
    Ziobro, Marek
    Switaj, Tomasz
    Falkowski, Slawomir
    Morysinski, Tadeusz
    Hetnal, Marcin
    Cedrych, Ida
    Rutkowski, Piotr
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (06): : 532 - 545
  • [49] Treatment patterns of advanced malignant melanoma (stage III-IV) - A review of current standards in Europe
    Harries, Mark
    Malvehy, Josep
    Lebbe, Celeste
    Heron, Louise
    Amelio, Justyna
    Szabo, Zsolt
    Schadendorf, Dirk
    EUROPEAN JOURNAL OF CANCER, 2016, 60 : 179 - 189
  • [50] Combined treatment of stage IV melanoma patients with amifostine and fotemustine - a pilot study
    Mohr, P
    Makki, A
    Breitbart, E
    Schadendorf, D
    MELANOMA RESEARCH, 1998, 8 (02) : 166 - 169
12345